Metaplastic breast cancer and BRCA1: first strong evidence of a link.
作者信息
Evans D Gareth R, Howell Anthony, Howell Sacha J
机构信息
Manchester for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Division of Evolution, Infection and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
出版信息
Eur J Hum Genet. 2023 Nov;31(11):1207-1208. doi: 10.1038/s41431-023-01441-6. Epub 2023 Aug 17.
Abstract
摘要
相似文献
1
Metaplastic breast cancer and BRCA1: first strong evidence of a link.化生性乳腺癌与BRCA1：首次出现两者存在关联的有力证据。
Eur J Hum Genet. 2023 Nov;31(11):1207-1208. doi: 10.1038/s41431-023-01441-6. Epub 2023 Aug 17.
2
BRCA1 germline mutation in a woman with metaplastic squamous cell breast cancer.一名患有化生性鳞状细胞乳腺癌的女性存在BRCA1基因种系突变。
Onkologie. 2007 Jun;30(6):316-8. doi: 10.1159/000101515. Epub 2007 May 29.
3
A deleterious BRCA1 mutation in a young Pakistani woman with metaplastic breast carcinoma.一名年轻巴基斯坦裔女性患有化生性乳腺癌，携带有害的 BRCA1 突变。
Pathol Res Pract. 2011 Sep 15;207(9):583-6. doi: 10.1016/j.prp.2011.05.011. Epub 2011 Jun 30.
4
Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.正常乳腺中BRCA1或BRCA2的种系突变与雌激素反应蛋白表达改变及孕激素受体A占优势有关。
Genes Chromosomes Cancer. 2004 Mar;39(3):236-48. doi: 10.1002/gcc.10321.
5
Clinical management of BRCA1 and BRCA2 mutation carriers.BRCA1和BRCA2基因突变携带者的临床管理。
Nat Clin Pract Oncol. 2006 Jan;3(1):2-3. doi: 10.1038/ncponc0384.
6
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.意大利乳腺癌和/或卵巢癌家族中新型BRCA1和BRCA2种系突变以及突变谱和患病率评估
Breast Cancer Res Treat. 2006 Nov;100(1):83-91. doi: 10.1007/s10549-006-9225-9. Epub 2006 May 9.
7
The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.视网膜母细胞瘤基因在 BRCA1 缺陷的基底样乳腺癌中发生重排。
Cancer Res. 2012 Aug 15;72(16):4028-36. doi: 10.1158/0008-5472.CAN-12-0097. Epub 2012 Jun 15.
8
Complex Characterization of Germline Large Genomic Rearrangements of the and Genes in High-Risk Breast Cancer Patients-Novel Variants from a Large National Center.高危乳腺癌患者中 和 基因种系大片段基因组重排的复杂特征——来自大型国家中心的新变异。
Int J Mol Sci. 2020 Jun 30;21(13):4650. doi: 10.3390/ijms21134650.
9
[Breast cancer in BRCA1/2 mutation carriers].[携带BRCA1/2基因突变的乳腺癌患者]
Cesk Patol. 2016 Fall;52(4):206-209.
10
Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients.BRCA1 和 BRCA2 种系变异在中国客家乳腺癌和卵巢癌患者中的分析。
BMC Cancer. 2022 Aug 2;22(1):842. doi: 10.1186/s12885-022-09943-0.
引用本文的文献
1
A case of high-grade adenosquamous carcinoma of the breast: case report and literature review.一例乳腺高级别腺鳞癌：病例报告及文献复习
Front Oncol. 2025 Mar 4;15:1548036. doi: 10.3389/fonc.2025.1548036. eCollection 2025.
2
The Role of the Fox Gene in Breast Cancer Progression.Fox基因在乳腺癌进展中的作用。
Int J Mol Sci. 2025 Feb 7;26(4):1415. doi: 10.3390/ijms26041415.
本文引用的文献
1
Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene.胚系致病性变异在骨化性乳腺肿瘤患者中的研究进展和 BRCA1 基因的作用
Eur J Hum Genet. 2023 Nov;31(11):1275-1282. doi: 10.1038/s41431-023-01429-2. Epub 2023 Jul 18.
2
Rare subtypes of triple negative breast cancer: Current understanding and future directions.三阴性乳腺癌的罕见亚型：当前认识与未来方向。
NPJ Breast Cancer. 2023 Jun 23;9(1):55. doi: 10.1038/s41523-023-00554-x.
3
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.乳腺癌风险基因 - 超过 113000 名女性的关联分析。
N Engl J Med. 2021 Feb 4;384(5):428-439. doi: 10.1056/NEJMoa1913948. Epub 2021 Jan 20.
4
A Population-Based Study of Genes Previously Implicated in Breast Cancer.基于人群的先前与乳腺癌相关的基因研究。
N Engl J Med. 2021 Feb 4;384(5):440-451. doi: 10.1056/NEJMoa2005936. Epub 2021 Jan 20.
5
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline Pathogenic Variant.新辅助 Talazoparib 治疗携致病性种系突变的可手术乳腺癌患者。
J Clin Oncol. 2020 Feb 10;38(5):388-394. doi: 10.1200/JCO.19.01304. Epub 2019 Aug 28.
6
Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.探讨化生性乳腺癌的表型和分子特征及其预后意义。
J Pathol. 2019 Feb;247(2):214-227. doi: 10.1002/path.5184. Epub 2018 Dec 20.
7
Pathology update to the Manchester Scoring System based on testing in over 4000 families.基于对 4000 多个家庭的检测，对曼彻斯特评分系统进行病理学更新。
J Med Genet. 2017 Oct;54(10):674-681. doi: 10.1136/jmedgenet-2017-104584. Epub 2017 May 10.
8
The Contribution of Whole Gene Deletions and Large Rearrangements to the Mutation Spectrum in Inherited Tumor Predisposing Syndromes.全基因缺失和大片段重排在遗传性肿瘤易感综合征突变谱中的作用
Hum Mutat. 2016 Mar;37(3):250-6. doi: 10.1002/humu.22938. Epub 2016 Jan 11.
9
Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].化生性乳腺癌表现出基因组和转录组的异质性[已修正]。
Mod Pathol. 2015 Mar;28(3):340-51. doi: 10.1038/modpathol.2014.142. Epub 2014 Nov 21.
10
Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.化生性乳腺癌患者的生存结局：基于美国人群分析的结果
Ann Surg Oncol. 2015 Jan;22(1):24-31. doi: 10.1245/s10434-014-3890-4. Epub 2014 Jul 11.
Zotero 插件